Table 1 Sociodemographic and clinical characteristics of the study patients

Subjects (N, %)

50,683

20,702

19,280

10,701

Follow-up time (person-years)

249,656.30

149,494.24

84,776.07

15,385.97

Age at diagnosis (years)

  Mean ± SD

35.4 ± 9.5

35.3 ± 9.2

35.3 ± 9.5

35.8 ± 9.9

  Range

18 – 89

18 – 89

18 – 86

18 – 85

Ethnicity

  Caucasian

18,399 (36.3)

3,087 (14.9)

9,454 (49.0)

5,858 (54.8)

  Mulatto (mixed white and black)

9,290 (18.3)

1,408 (6.8)

4,701 (24.4)

3,181 (29.7)

  Black

2,912 (5.8)

478 (2.3)

1,520 (7.9)

914 (8.5)

  Others (Asian, Indigenous…)

307 (0.6)

64 (0.3)

132 (0.7)

111 (1.0)

  Unspecified

19,775 (39.0)

15,666 (75.7)

3,473 (18.0)

637 (6.0)

Deaths^a

10.326

5.791

3.258

1.277

Have at least one CD4 exam available on SISCEL

  No

14,934 (29.5)

8.081 (39.0)

4.082 (21.2)

2,771 (25.9)

  Yes

35,749 (70.5)

12.621 (61.0)

15.198 (78.8)

7,930 (74,1)

CD4 lymphocytes, cells/mm³ (first exam available)^b

  Mean ± SD

298.1 ± 185.3

324.8 ± 179.3

289.5 ± 191.7

261.9 ± 177.0

  Range

0 – 999

0 – 998

0 – 998

0 – 999

Have at least one HIV-1 RNA Viral load exam available on SISCEL

  No

21,562 (42.5)

11,097 (53.6)

6,601 (34.2)

3,864 (36.1)

  Yes

29,121 (57.5)

9.605 (46.4)

12,679 (65.8)

6,837 (63.9)

HIV RNA in plasma, log₁₀ copies/ml (first exam available)^c

  Mean ± SD

4.46 ± 1.01

4.38 ± 1.04

4.46 ± 1.02

4.60 ± 0.91

  Range

1.70 – 6.69

1.70 – 6.67

1.70 – 6.69

1.70 – 6.69